The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)

Updated safety and efficacy analysis comparing elderly vs nonelderly patients treated with consolidation nivolumab or nivolumab plus ipilimumab after chemoradiation for unresectable stage III NSCLC from the BTCRC LUN 16-081 clinical trial.

Shobha  Shahani

No Relationships to Disclose

Sandra K.  Althouse

No Relationships to Disclose

Nasser H.  Hanna

Research Funding - Bristol-Myers Squibb (Inst); Genentech (Inst); Merck KGaA (Inst); Signatera (Inst)

Greg Andrew  Durm

Employment - Cook Biotech

Honoraria - AstraZeneca; Curio Science; Dava Oncology

Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Merck (Inst); Mirati Therapeutics (Inst)